Enantioselective inhibition of ampomorphine-induced emesis in the ferret by the neurokinin1 receptor antagonist CP-99,994
- 28 February 1994
- journal article
- research article
- Published by Elsevier in Neuropharmacology
- Vol. 33 (2) , 259-260
- https://doi.org/10.1016/0028-3908(94)90018-3
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- The 5-hydroxytryptamine receptor antagonists as antiemetics: Preclinical evaluation and mechanism of actionEuropean Journal Of Cancer, 1993
- Anti-emetic profile of a non-peptide neurokinin NK1 receptor antagonist, CP-99,994, in ferretsEuropean Journal of Pharmacology, 1993
- The tachykinin NK1 receptor antagonist CP-99,994 attenuates cisplatin induced emesis in the ferretEuropean Journal of Pharmacology, 1993
- Ondansetron Compared with High-Dose Metoclopramide in Prophylaxis of Acute and Delayed Cisplatin-Induced Nausea and VomitingAnnals of Internal Medicine, 1990
- PREVENTION OF EMESIS IN PATIENTS RECEIVING CYTOTOXIC DRUGS BY GR38032F, A SELECTIVE 5-HT3 RECEPTOR ANTAGONISTThe Lancet, 1987
- 5-hydroxytryptamine m-receptor antagonism to prevent cisplatin-induced emesisNeuropharmacology, 1986
- Inhibition of cisplatin‐induced vomiting by selective 5‐hydroxytryptamine M‐receptor antagonismBritish Journal of Pharmacology, 1986
- The physiology and pharmacology of emesisMolecular Aspects of Medicine, 1984